Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia

被引：7

作者：

Gauchy, Anne-Cecile ^{[1
,2
]}

Hentzien, Maxime ^{[2
,3
]}

Wynckel, Alain ^{[4
]}

de Marcellus, Victoire ^{[1
,2
]}

Rodier, Cyrielle ^{[1
,2
]}

Delmer, Alain ^{[1
,2
]}

Quinquenel, Anne ^{[1
,2
]}

机构：

[1] Ctr Hosp Univ, Hop Robert Debre, Serv Hematol Clin, Reims, France

[2] Univ Reims, UFR Med, Reims, France

[3] Ctr Hosp Univ, Hop Robert Debre, Serv Med Interne Malad Infect & Immunol Clin, Reims, France

[4] Ctr Hosp Univ, Hop Robert Debre, Serv Nephrol, Reims, France

来源：

CLINICAL CASE REPORTS | 2020年 / 8卷 / 12期

关键词：

chronic myelomonocytic leukemia; eculizumab; warm autoimmune hemolytic anemia; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; DISORDERS; RITUXIMAB; DISEASES;

D O I：

10.1002/ccr3.3250

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Eculizumab may be considered as an emergency therapeutic option in refractory life-threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments.

引用

页码：2641 / 2644

页数：4

共 13 条

[1] Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis [J].

Benamu, Esther ;

Montoya, Jose G. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (04) :319-329

[2] Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia [J].

Fraison, Jean-Baptiste ;

Mekinian, Arsene ;

Grignano, Eric ;

Kahn, Jean-Emmanuel ;

Arlet, Jean-Benoit ;

Decaux, Olivier ;

Denis, Guillaume ;

Buchdahl, Anne-Laure ;

Omouri, Mohamed ;

Maigne, Gwenola ;

Aouba, Achille ;

Leon, Nathalie ;

Berthier, Sabine ;

Liozon, Eric ;

Park, Sophie ;

Gardin, Claude ;

Lortholary, Olivier ;

Rossignol, Julien ;

Fenaux, Pierre ;

Fain, Olivier ;

Braun, Thorsten .

LEUKEMIA RESEARCH, 2016, 43 :13-17

[3] Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review [J].

Grignano, Eric ;

Mekinian, Arsene ;

Braun, Thorsten ;

Liozon, Eric ;

Hamidou, Mohamed ;

Decaux, Olivier ;

Puechal, Xavier ;

Kahn, Jean Emmanuel ;

Schoindre, Yoland ;

Rossignol, Julien ;

Lortholary, Olivier ;

Lioger, Bertrand ;

Hermine, Olivier ;

Park, Sophie ;

Ades, Lionel ;

Montestruc, Francois ;

Ricard, Laure ;

Gardin, Claude ;

Fenaux, Pierre ;

Fain, Olivier .

LEUKEMIA RESEARCH, 2016, 47 :136-141

[4] Immune thrombocytopenia in chronic myelomonocytic leukemia [J].

Hadjadj, Jerome ;

Michel, Marc ;

Chauveheid, Marie-Paule ;

Godeau, Bertrand ;

Papo, Thomas ;

Sacre, Karim .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) :521-526

[5] Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy [J].

Ma, Kim ;

Caplan, Stephen .

CASE REPORTS IN HEMATOLOGY, 2016, 2016

[6] Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies [J].

Meulenbroek, Elisabeth M. ;

de Haas, Masja ;

Brouwer, Conny ;

Folman, Claudia ;

Zeerleder, Sacha S. ;

Wouters, Diana .

HAEMATOLOGICA, 2015, 100 (11) :1407-1414

[7] A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution [J].

Peker, Deniz ;

Padron, Eric ;

Bennett, John M. ;

Zhang, Xiaohui ;

Horna, Pedro ;

Epling-Burnette, Pearlie K. ;

Lancet, Jeffrey E. ;

Pinilla-Ibarz, Javier ;

Moscinski, Lynn ;

List, Alan F. ;

Komrokji, Rami S. ;

Zhang, Ling .

ACTA HAEMATOLOGICA, 2015, 133 (02) :249-256

[8] Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies [J].

Reynaud, Quitterie ;

Durieu, Isabelle ;

Dutertre, Marine ;

Ledochowski, Stanislas ;

Durupt, Stephane ;

Michallet, Anne-Sophie ;

Vital-Durand, Denis ;

Lega, Jean-Christophe .

AUTOIMMUNITY REVIEWS, 2015, 14 (04) :304-313

[9] Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial [J].

Roeth, Alexander ;

Bommer, Martin ;

Huettmann, Andreas ;

Herich-Terhuerne, Doerte ;

Kuklik, Nils ;

Rekowski, Jan ;

Lenz, Veronika ;

Schrezenmeier, Hubert ;

Duehrsen, Ulrich .

BLOOD ADVANCES, 2018, 2 (19) :2543-2549

[10] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia [J].

Scott, Lesley J. .

DRUGS, 2016, 76 (08) :889-900

← 1 2 →